Comprehensive
Heart Health Analytics
for Greater Longevity
Cardiolyse is a cloud ECG & HRV analytics platform, that enables real-time remote heart health monitoring, providing plain personalized reports, detection and up to two months data-based prognosis on dangerous heart events
We deliver a holistic approach to prevent heart disorders for elevated risk groups, using innovative and clinically proven machine-learning algorithms
Monitor
Cloud solution for affordable real-time remote heart health monitoring through any leads digital ECG device integration
Analyze
Clinically proven machine-learning algorithms that analyze up to 400 vital ECG parameters and detect all types of Arrythmias, Atrial Fibrillation, Myocardial Infarction, Ventricular Hypertrophy
Predict
Patent-pending Universal ECG and Personal Baseline Scores to precisely predict heart attacks and strokes up to 2 months before they occur
Prevent
Personalized reports on vital cardiac parameters values to timely adjust medication and patient's lifestyle, increasing access to preventive care
Remote Real-time Heart Health Monitoring
Allows to accurately determine the position of every cardiac parameter on a scale from a personal baseline to pathology to prevent dangerous heart events for elevated risk groups
Diabetes Cardiovascular Comorbidities Prevention
Provides an integrated solution for primary prevention of cardiovascular complications in diabetes with specific cardiac parameters monitoring, timely disease CVD risk detection and cure
Fatigue Risk Management
Comprehensive liability insurance solution and alert system for seamless real-time fatigue risks monitoring in critical safety job performers to prevent further accidents
Benefits
for corporate sector
Comprehensive clinically-proven and CE-certified, yet affordable tracking of all-known vital parameters to ease and speed-up the patient diagnosticating for cardiologists, general practitioners and healthcare providers
Healthcare system cost burden reduction, driven by eliminated physician office visits, dangerous heart events and hospital readmission prevention with timely cardiovascular risk detection and early treatment intervention
Plain, patient- and doctor-adapted visually compelling cardiac health reports, enabling patients to take control of and positively impact their health with necessary lifestyle adjustments
Team
Meet our health passionate and expert global team, standing behind the Cardiolyse platform development and growth
Advisory Board
Pulli Global Development Advisor Executive with 25+ years of experience in Business Development (ex-CEO Chiezi)
Pirttiaho Global Development Advisor MedTech solutions growth expert with 15+ years in sales for large and small ventures
Gualerzi Scientific Advisor Experienced medical director and cardiologist, leading non-profit's and corporate scientific divisions
News
Cardiolyse Cardiac Analytics solution in COVID-19 Disruptive circumstances
Cardiolyse aims to support the high-risk groups’ cardiac health monitoring and management in Coronavirus pandemic circumstances At the disruptive times with the COVID-19 outbreak growing Cardiolyse is all-hands ready to expand the availability of our platform and deliver the solution to those of high cardiac risk and elderly people currently isolated at home or restricted from safe & easy medical […]
Read more
Cardiolyse presenting its solution at Arab Health 2020
Moving on with our global partners’ outreach Good news this time comes from Dubai, where Arab Health, the leading healthcare business event in the Middle East has taken place. Cardiolyse was represented by our business development advisor, Normunds Daudiss. We were selected to deliver a pitch at Innov8 talks and Normunds has won the first day of competition, presenting Cardiolyse […]
Read more
Cardiolyse pitched at corporate challenges at HTH Styria Pitch & Partner event
Greetings from Graz, Austria! The part of our team is these days participating in HTH Styria Pitch & Partner event #HTHStyria. Cardiolyse has been selected out of 70+ companies to present our solution on 2 corporate challenges out of 4 organized by the event hosts. It’s been two insightful days of great inspiration, deep and productive networking, as well as […]
Read more
CE certificate for class IIa software medical device issued
A year of new achievements and new happiness started just perfectly with Cardiolyse finally receiving its CE and ISO certification papers! We’re certified as a standalone software medical device for automatic ECG interpretation, which now fully opens all the doors for sustainable commercial partnerships with hospitals, pharmacies, GP networks, and other digital health market disruptive players. Within the certification process, […]
Read more
Cardiolyse was issued with a US patent for its proprietary Method of ECG evaluation
One of Cardiolyse product core technologies for the unique Method of ECG Evaluation to deliver personalized cardiac risk assessment has been issued with the US patent! The patent covers the invention of the Universal ECG Score, which is designed to diagnose the cardiovascular system based on at least 148 quantitative ECG parameters rating and aggregation. The score calculated provides the […]
Read moreSend us a word regarding any question or suggestion you have
Let’s work together
on heart health improvement